MedTrace Logo

Immunopathology of Autoimmune Hemolytic Anemia

NCT02158195 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 27

Last updated 2026-02-09

No results posted yet for this study

Summary

Autoimmune hemolytic anemia (AIHA) is an auto-immune disease mediated by specific antibodies targeting red blood cells. Its pathogenesis is not completely understood, and the role of T cells have been rarely studied.

The aim of this study is to compare the frequency of circulating T cells, T cell polarization and functions, notably regulatory T cells, during warm AIHA by comparison to healthy controls.

The role of treatments, such as steroids, will also be determined in patients with warm AIHA.

Conditions

  • Autoimmune Hemolytic Anemia

Interventions

BIOLOGICAL

blood samples

Sponsors & Collaborators

  • Centre Hospitalier Universitaire Dijon

    lead OTHER

Eligibility

Min Age
16 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-07-03
Primary Completion
2018-12-27
Completion
2018-12-27

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02158195 on ClinicalTrials.gov